Published: Published Date - 05:59 PM, Mon - 30 August 21
The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad.
Hyderabad: Hyderabad-based Granules India said it received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of arthritis pain.
The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad. The product is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets.
Priyanka Chigurupati, ED, Granules USA & Granules Pharmaceuticals, said, “We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen Extended-Release Tablets OTC, 650mg, a complex Bi-layer Extended Released based formulation, is a good addition to our portfolio. We will be launching the product in the Canada market soon.”
Granules now have a total of two ANDS (abbreviated new drug submissions) approvals from Health Canada.
Now you can get handpicked stories from Telangana Today onTelegrameveryday. Click the link to subscribe.